AfriCoVER: Characterising transmission parameters of SARS-CoV-2 in peri-urban setting in Mozambique using population-based surveillance and high-throughput sero-assay

  • Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Total publications:3 publications

Grant number: RIA2020EF-3031

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $554,988.9
  • Funder

    European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Principal Investigator

    Pending
  • Research Location

    Mozambique
  • Lead Research Institution

    Prins Leopold Instituut voor Tropische Geneeskunde (ITM)
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The AfriCoVER project (RIA2020EF-3031) aims to conduct population-based surveillance in a Demographic Health Surveillance System (HDSS) of 16,500 people in a peri-urban neighbourhood of Maputo, Mozambique, by collecting clinical information and respiratory specimens from patients during biweekly household visits, complemented with data from local clinics.

Publicationslinked via Europe PMC

Mild and moderate COVID-19 during Alpha, Delta and Omicron pandemic waves in urban Maputo, Mozambique, December 2020-March 2022: A population-based surveillance study.

Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.

Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay.